“SGLT2 Inhibitors: Cardiorenal Mechanisms How a Glucose-Lowering Drug Became a Foundational Heart and Kidney Therapy”. Diabzen, vol. 4, no. 14, July 2026, pp. 28-29, https://thediabzen.com/index.php/d/article/view/56.